Importantly, we demonstrated that the tumour-to-muscle ratio of 89Zr-DFO-6E11 PET in this experimental setup was predictive of response to PD-L1 immune checkpoint inhibition in a syngeneic mouse tumour model. This evidence concerns the gene CD274 and neoplasm.